Isabel Fernández-Pisonero

5PUBLICATIONS
25CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 31, 2025
Active R-RAS2/TC21 prevents cell cycle arrest and morphological alterations in mouse embryonic fibroblasts lacking RAS proteins.

Isabel Fernández-Pisonero, L Francisco Lorenzo-Martín, Mattias Drosten

|Dec 08, 2022
Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors.

Laura Clavaín, Isabel Fernández-Pisonero, Nieves Movilla

|Oct 07, 2021
Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.

Javier Robles-Valero, Lucía Fernández-Nevado, L Francisco Lorenzo-Martín

|Nov 17, 2020
Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis.

Sonia Rodríguez-Fdez, L Francisco Lorenzo-Martín, Isabel Fernández-Pisonero

|May 31, 2018
R-Ras2 is required for germinal center formation to aid B cells during energetically demanding processes.

Pilar Mendoza, Nuria Martínez-Martín, Elena R Bovolenta

Pageof 1